Loading...
Loading...
Onward Medical N.V./ADR
Onward Medical N.V./ADR. Spoken Alpha tracks ONWRF's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks ONWRF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 70% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ONWRF.
curl https://api.spokenalpha.com/v1/companies/ONWRF| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.04 | $2.17 | +40.2% | -6.1% | -8.3% |
| Q4 FY2026 | $3.09 | $2.25 | +37.5% | -3.7% | -5.7% |
| Q3 FY2026 | $3.08 | $2.33 | +32.0% | -4.6% | -6.8% |
| Q2 FY2026 | $3.03 | $2.19 | +38.3% | +4.0% | +5.5% |
| Q1 FY2025 | $3.09 | $2.27 | +36.0% | -2.8% | -1.5% |
| Q4 FY2025 | $3.08 | $2.29 | +34.4% | -1.2% | -3.4% |
| Q3 FY2025 | $3.42 | $2.36 | +44.8% | +2.7% | +4.8% |
| Q2 FY2025 | $3.20 | $2.25 | +42.1% | +4.7% | +5.0% |
| Q1 FY2024 | $3.38 | $2.39 | +41.3% | -3.4% | -4.7% |
| Q4 FY2024 | $3.08 | $2.18 | +41.5% | -0.5% | +2.1% |